Malignancies in HIV infected patients: Study of 139 cases;Tumores en pacientes con infección por el virus de la inmunodeficiencia humana: estudio de 139 casos

Medicina Clinica

Volumn 133, Issue 19, 2009, Pages 729-735

  Ramírez Olivencia, Germán ^a   Valencia Ortega, María Eulalia ^a   Martin Carbonero, Luz ^a   Moreno Celda, Victoria ^a   González Lahoz, Juan ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Cancer; Highly active antiretroviral therapy; Human immunodeficiency virus; Tumor

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER SURVIVAL; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GYNECOLOGIC CANCER; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION RISK; KAPOSI SARCOMA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MIXED INFECTION; MORTALITY; NONHODGKIN LYMPHOMA; PROGNOSIS; VIRUS LOAD;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS;

EID: 70350786272     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2009.03.043     Document Type: Article

References (36)

1. Núñez M. Hepatotoxicity of antiretrovirals: Incidence, mechanisms and management. J Hepatol 44 (2006) S132-S139
2. Roling J., Schmid H., Fischereder M., Draenert R., and Goebel F.D. HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. Clin Infect Dis 42 (2006) 1488-1495
3. Samaras K. Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection. J Antimicrob Chemother 61 (2008) 238-245
4. Brau N., Fox R.K., Xiao P., Marks K., Naqvi Z., Taylor L.E., et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A US-Canadian multicenter study. J Hepatol 47 (2007) 527-537
5. Giordano T.P., Kramer J.R., Souchek J., Richardson P., and El-Serag H.B. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: A cohort study, 1992-2001. Arch Intern Med 164 (2004) 2349-2354
6. Centers for Disease Control (CDC) Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States. MMWR Morb Mortal Wkly Rep 34 (1985) 373-375
7. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41 (1992) 1-19
8. Barbaro G., and Barbarini G. HIV infection and cancer in the era of highly active antiretroviral therapy (review). Oncol Rep 17 (2007) 1121-1126
9. Bedimo R., Chen R.Y., Accortt N.A., Raper J.L., Linn C., Allison J.J., et al. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. Clin Infect Dis 39 (2004) 1380-1384
10. Bonnet F., Lewden C., May T., Heripret L., Jougla E., Bevilacqua S., et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 101 (2004) 317-324
11. Crum N.F., Riffenburgh R.H., Wegner S., Agan B.K., Tasker S.A., Spooner K.M., et al. Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 41 (2006) 194-200
12. Frisch M., Biggar R.J., Engels E.A., Goedert, and AIDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA 285 (2001) 1736-1745
13. Galceran J., Marcos-Gragera R., Soler M., Romaguera A., Ameijide A., Izquierdo A., et al. Cancer incidence in AIDS patients in Catalonia, Spain. Eur J Cancer 43 (2007) 1085-1091
14. Martinez E., Milinkovic A., Buira E., De Lazzari E., León A., Larrousse M., et al. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV Med 8 (2007) 251-258
15. Palella Jr. F.J., Baker R.K., Moorman A.C., Chmiel J.S., Wood K.C., Brooks J.T., et al. Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 43 (2006) 27-34
16. Sabin C.A., Smith C.J., Youle M., Lampe F.C., Bell D.R., Puradiredja D., et al. Deaths in the era of HAART: Contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers. AIDS 20 (2006) 67-71
17. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden E.T., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
18. Carbone P.P., Kaplan H.S., Musshoff K., Smithers D.W., and Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31 (1971) 1860-1861
19. Shepherd J.H. Cervical and vulva cancer: Changes in FIGO definitions of staging. Br J Obstet Gynaecol 103 (1996) 405-406
20. Engels E.A., and Goedert J.J. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: Past, present and future. J Natl Cancer Inst 97 (2005) 407-409
21. Navarro W.H., and Kaplan L.D. AIDS-related lymphoproliferative disease. Blood 107 (2006) 13-20
22. Bonnet F., Lewden C., May T., Heripret L., Jougla E., Bevilacqua S., et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 101 (2004) 317-324
23. Carrieri M.P., Pradier C., Piselli P., Piche M., Rosenthal E., Heudier P., et al. Reduced incidence if Kaposi's sarcoma and of systemic non-Hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy. Int J Cancer 103 (2003) 142-144
24. Dal Maso L., and Franceschi S. Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncol 4 (2003) 110-119
25. Miralles P., Berenguer J., Ribera Santasusana J.M., Calvo F., Díaz Mediavilla J., Diez-Martin J.L., et al. GESIDA/PETHEMA guidelines for the diagnosis and treatment of lymphomas in HIV-infected patients. Med Clin (Barc) 130 (2008) 300-311
26. Moodley J.R., Hoffman M., Carrara H., Allan B.R., Cooper D.D., Rosenberg L., et al. HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: A case-control study. BMC Cancer 6 (2006) 135
27. Ellerbrock T.V., Chiasson M.A., Bush T.J., Sun X.W., Sawo D., Brudney K., et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 283 (2000) 1031-1037
28. Heard I., Schmitz V., Costagliola D., Orth G., and Kazatchkine M.D. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 12 (1998) 1459-1464
29. Palefsky J.M., Minkoff H., Kalish L.A., Levine A., Sacks H.S., García P., et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 91 (1999) 226-236
30. Lomalisa P., Smith T., and Guidozzi F. Human immunodeficiency virus infection and invasive cervical cancer in South Africa. Gynecol Oncol 77 (2000) 460-463
31. Davis A.T., Chakraborty H., Flowers L., and Mosunjac M.B. Cervical dysplasia in women infected with the human immunodeficiency virus (HIV): A correlation with HIV viral load and CD4+ count. Gynecol Oncol 80 (2001) 350-354
32. Gichangi P.B., Bwayo J., Estambale B., De Vuyst H., Ojwang S., Rogo K., et al. Impact of HIV infection on invasive cervical cancer in Kenyan women. AIDS 17 (2003) 1963-1968
33. Leitao Jr. M.M., White P., and Cracchiolo B. Cervical cancer in patients infected with the human immunodeficiency virus. Cancer 112 (2008) 2683-2689
34. Gates A.E., and Kaplan L.D. AIDS malignancies in the era of highly active antiretroviral therapy. Oncology 16 (2002) 657-665
35. Engels E.A., Pfeiffer R.M., Goedert J.J., Virgo P., McNeel T.S., Scoppa S.M., et al. Trends in cancer risk among people with AIDS in the United States 1980-002. AIDS 20 (2006) 1645-1654
36. Pradier C., Carrieri M., Piche M., Rosenthal E., Dellamonica P., and Serraino D. HCV infection and cancer risk among HIV-infected individuals. Infection 3 (2003) 194-196